Angiosarcoma clinical trials at UCSF

1 research study open to eligible people

Angiosarcoma is a rare cancer that starts in the lining of blood vessels. UCSF is studying new drugs to treat this cancer through several clinical trials. These trials include testing personalized medicines to find the best treatment for each patient.

Showing trials for

  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Last updated: